Overview

A Study in People With High Cholesterol

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine: - The safety of the study medication and any side effects that might be associated with it - Whether the study medication can help patients with high levels of "bad" cholesterol (low-density lipoprotein-cholesterol [LDL-C]), alone or in combination with additional study medication
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Atorvastatin
Atorvastatin Calcium